(Q47263654)

12 January 2018

title

Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases (English)

1 reference

12 January 2018

author name string

Fordy C

1

1 reference

12 January 2018

Glover C

2

1 reference

12 January 2018

Henderson DC

3

1 reference

12 January 2018

Summerbell C

4

1 reference

12 January 2018

Wharton R

5

1 reference

12 January 2018

Allen-Mersh TG

6

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

12 January 2018

British Journal of Surgery

published in

1 reference

12 January 2018

volume

86

1 reference

12 January 2018

issue

5

1 reference

12 January 2018

page(s)

639-644

1 reference

12 January 2018

Cancer cachexia: pathophysiological mechanisms

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Improving survival after large bowel cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Measurement of response to treatment in colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Decreased interleukin-2 production in patients with gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Interleukin-6: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Molecular characterization of defective antigen processing in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Pharmacological treatment of cachexia: any progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01086.X

10.1046/J.1365-2168.1999.01086.X

21 January 2018

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018